Urology practice during the COVID-19 pandemicVincenzo Ficarra, F. Porpiglia, Giacomo Novara et al.|Minerva Urologica e Nefrologica|2020Cited by 256
Robotic assisted simple prostatectomy versus other treatment modalities for large benign prostatic hyperplasia: a systematic review and meta-analysis of over 6500 casesSavio Domenico Pandolfo, Fabio Crocerossa, Marco De Sio et al.|Prostate Cancer and Prostatic Diseases|2022Cited by 63
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancerMatteo Ferro, Mihai Dorin Vartolomei, Biagio Barone et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 56
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumorMatteo Ferro, Giuseppe Lucarelli, Martha Orsolya Katalin et al.|Urologic Oncology Seminars and Original Investigations|2020Cited by 48
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin ImmunotherapyMatteo Ferro, Ottavio De Cobelli, Octavian Sabin Tătaru et al.|Diagnostics|2022Cited by 41